EU panel rejects Pfizer's tanezumab for osteoarthritis pain - - Pharmaphorum

Retrieved on: 2021-09-19 14:26:15

Tags for this article:

Medical specialties

Branches of biology

Monoclonal antibodies

Tanezumab

Nerve growth factor inhibitor

Nonsteroidal anti-inflammatory drugs

Pfizer

Osteoarthritis

Click the tags to see associated articles and topics

EU panel rejects Pfizer's tanezumab for osteoarthritis pain - - Pharmaphorum. View article details on hiswai:

Excerpt

Any lingering hope that Pfizer's may finally get a regulatory approval for its nerve growth factor (NGF) inhibitor tanezumab looks to have been dashed after ...

Article found on: pharmaphorum.com

View Original Article